You are here

Pursuit Vascular Announces Attendance at ANNA 2019 National Symposium

MAPLE GROVE, Minn., April 10, 2019 /PRNewswire/ -- Pursuit Vascular, Inc., manufacturer of ClearGuard® HD Antimicrobial Barrier Caps, today announced it will be exhibiting at the American Nephrology Nurses Association 2019 National Symposium taking place in Dallas, Texas next week. 

With a membership of over 8500 registered nurses and other health professionals, the American Nephrology Nurses Association (ANNA) is the professional organization for nephrology nurses.  Members actively participate in hemodialysis, end-stage kidney disease, continuous renal replacement therapies, vascular access and transplantation within hospitals and free-standing centers.  ANNA members are leaders who advocate for patients, mentor one another, and lobby legislators to inspire excellence. 

This year's conference takes place at the Hilton Anatole in Dallas April 14-17, 2019.  Pursuit Vascular will be exhibiting at booth #429 where the company will be promoting their ClearGuard HD caps, the first and only device available in the US designed to kill infection-causing microorganisms inside a hemodialysis catheter hub.  ClearGuard HD caps have been proven to reduce bloodstream infections by ~70% in hemodialysis catheter patients.

About Pursuit Vascular

Headquartered in Maple Grove, Minnesota, Pursuit Vascular, Inc., develops innovative products designed to protect patients from life-threatening infections, their associated complications, and death, while reducing healthcare costs worldwide.  The company's ClearGuard HD Antimicrobial Barrier Cap is the first and only device available for sale in the US that is proven to reduce central line-associated bloodstream infections in hemodialysis patients.  For more information, visit


Cision View original content to download multimedia:

SOURCE Pursuit Vascular, Inc.